A prospective study on the quantification of anti-HBs antibody titers of vaccinated health care workers in a tertiary care teaching hospital by using automated enzyme linked fluorescent assay
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20223552Keywords:
AHBS, Anti-HBs antibodies, Antibody titer, Health care workers, Hepatitis B virus, VaccinationAbstract
Background: Hepatitis B virus (HBV) infection poses a major health problem among health care workers (HCWs). Globally, 350 million peoples have infected, and it was estimated by WHO. CDC has recommended HBV vaccination for all health care workers. The objective was to determine the anti-HBs antibodies titres among health care workers using automated enzyme linked fluorescent assay (ELFA).
Methods: This prospective study was conducted in department of microbiology, tertiary care hospital. The test samples have been collected from health care workers who have completed the course of vaccination. VIDAS anti-HBs total II (AHBS) assay was initiated according to the manufacturer’s instructions.
Results: Out of 100 subjects, 62% showed positive for anti-HBs antibodies and the remaining 38% showed negative. Positivity of anti-HBs antibody titers ranges from 27 mIU/ml to 500 mIU/ml.
Conclusions: In the present study, 100 subjects have been selected based on the HBV vaccination with completion of three doses of vaccination. Presence of anti-HBs antibodies titers against the vaccination is fully immunized. The study was determined the vaccinated status of anti-HBs antibodies against the infection among clinicians, nurses and CRRIs and it has to be revealed at regular intervals of every 6 to 8 months.
Metrics
References
Sharma T, Mittal G, Kalra C, Agarwal RK, Rawat BS. Anti-HBs antibodies over time in healthcare workers after hepatitis B vaccination. Indian J Comm Health. 2019;31:144-9.
Centers for Disease Control and Prevention (CDC. Immunization of health-care workers: recommendation of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HIPAC). Morbid Mortal Week Rep. 1997;46:1-42.
World Health Organisation. Hepatitis B vaccine. Week Epidemiol Record. 2017;92(27):369-92.
Lall M, Sen S, Patrikar S, Karade S, Gupta RM. Post vaccination antibody titres of hepatitis B surface antigen (anti-HBs) in a mixed cohort of health care workers. Med J Armed Forces India. 2022;78(2):198-203.
Vidas Anti-HBs Total II [packet insert]. Marcy-I’Etoile-France: Biomerieux; 2013. Available from: https://www.biomerieux-diagnostics.com. Accessed on 2 December 2021.
Lakshmanan KP, Bhaumik P, Sarkar P. Study of immunisation status by estimation of anti-HBs antibody in post hepatitis B vaccinated individuals. J Evid Based Med Health. 2017;4(79):4656-60.
Popping S, Bade D, Boucher C, Van Der Walk M, El-Sayed M, Sigurour O, et al. The global campaign to eliminate HBV and HCV infection: international Viral hepatitis elimination meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019;5(1):60-6.
Ravikumar S, Katragadda R, Abishek B. A cross sectional study for detection of Anti-HBs Antibody among Health Care workers. Int J Curr Microbiol App Sci. 2018;7(6):1934-9.
Regha IR, Salim SP. Estimation of anti-hepatitis B antibody status of vaccinated health care workers in a medical college hospital in central Kerala, India. Nat J Lab Med. 2020;9(3):MO01-4.
Iftekhar W, Angali N, Mohan MVNLR, Ahamed B, Teja VD. Evaluation of antibodies to hepatitis B (Anti-HBs) titres in health care workers in a tertiary care centre. IP Int. J Med Microbiol Trop Dis. 2020;6(1):62-5.
Jagan AO, Joseph C, Oommen S. Anti-HBS antibody status of healthcare workers in Pushpagiri Institute of Medical Sciences and Research Centre. Pushpagiri Med J. 2014;5(2):111-3.
Gopalakrishnan R, Srinath RS. Seroprevalence of hepatitis B infection among health care workers and the importance of anti HBs testing among the health care workers. Int J Curr Microbiol App Sci. 2017;6(10):228085.
Batra V, Goswami A, Dadhich S, Kothari D, Bhargava N. Hepatitis B immunisation in healthcare workers. Ann Gastroenterol. 2015;28(2):276-80.
Di Giampaolo L, Costantini E, Di Nicola M, Porreca A, D'Amore G, Coppeta L, et al. Titre of anti-HBs in health professions trainees: prevalence of antibody coverage in a University of Central Italy. Hum Vaccine Immunother. 2022;18(1):1886805.
Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
Singhal V, Bora D, Singh S. Hepatitis B in health care workers: Indian scenario. J Lab Phys. 2009;1(2):41-8.
Ray G. Current scenario of Hepatitis B and its treatment in India. J Clin Transl Hepatol. 2017;5(3):277-96.
Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018;6(13):589-99.
Sukriti, Pati NT, Sethi A, Agarwal K, Agarwal K, Kumar GT, et al. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. J Gastroenterol Hepatol. 2008;23(11):1710-5.
Beltrami EM, Williams IT, Shaprio CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev. 2000;13(3):385-407.
Van Der Scheun FC, Nagelkerke MCM, Kilaru A, Shridhar V, Prasad R, van der Werf TS. Stigma among healthcare workers towards hepatitis B infection in Bangalore, India: a qualitative study. BMC Health Serv Res. 2019;19:736.
Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, et al. Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine. Vaccine. 2013;31(3):448-51.